Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells

Journal of Cellular Physiology

Volumn 207, Issue 2, 2006, Pages 471-479

  Lochrie, Jennifer D ^a   Phillips, Kirsten ^a   Tonner, Elizabeth ^a   Flint, David J ^a   Allan, Gordon J ^a   Price, Nicholas C ^b   Beattie, James ^a  

^a HANNAH RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; CASPASE 3; DEXAMETHASONE; HYDROCORTISONE; INSULIN; PROLACTIN; SOMATOMEDIN BINDING PROTEIN 5; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; INVOLUTION; LACTATION; MOUSE; NONHUMAN; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CASEINS; CASPASE 3; CASPASES; CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HYDROCORTISONE; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MAMMARY GLANDS, ANIMAL; MICE; PREGNANCY; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; UP-REGULATION;

ANIMALIA; RODENTIA;

EID: 33645580546     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20587     Document Type: Article

References (48)

1. Allar MA, Wood TL. 2004. Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology 145(5):2467-2477.
2. Bailey JP, Nieport KM, Herbst MP, Srivastava S, Serra RA, Horseman ND. 2004. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol Endocrinol 18(5):1171-1184.
3. Blatchford DR, Hendry KA, Wilde CJ. 1998. Autocrine regulation of protein secretion in mouse mammary epithelial cells. Biochem Biophys Res Commun 248(3):761-766.
4. Bonnette SG, Hadsell DL. 2001. Targeted disruption of the igf-i receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142(11):4937-4945.
5. Boutinaud M, Shand JH, Park MA, Phillips K, Beattie J, Flint DJ, Allan GJ. 2004. A quantitative RT-PCR study of the mRNA expression profile of the IGF axis during mammary gland development. J Mol Endocrinol 33(1):195-207.
6. Bramani S, Allan GJ, Beattie J. 1999. Characterization of the IGF axis in a rat liver-derived epithelial cell line. Growth Horm IGF Res 9(6):425-433.
7. Butt AJ, Dickson KA, McDougall F, Baxter RC. 2003. Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278(32):29676-29685.
8. Cheng HL, Shy M, Feldman EL. 1999. Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. Endocrinology 140(10):4478-4485.
9. Ewton DZ, Coolican SA, Mohan S, Chernausek SD, Florini JR. 1998. Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5. J Cell Physiol 177(1):47-57.
10. Faure E, Heisterkamp N, Groffen J, Kaartinen V. 2000. Differential expression of TGF-beta isoforms during postlactational mammary gland involution. Cell Tissue Res 300(1):89-95.
11. Fernandes-Alnemri T, Litwack G, Alnemri ES. 1994. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269(49):30761-30764.
12. Fielder PJ, Thordarson G, English A, Rosenfeld RG, Talamantes F. 1992. Expression of a lactogen-dependent insulin-like growth factor-binding protein in cultured mouse mammary epithelial cells. Endocrinology 131(1):261-267.
13. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23(6):824-854.
14. Flint DJ, Tonner E, Allan GJ. 2000. Insulin-like growth factor binding proteins: IGF-dependent and -independent effects in the mammary gland. J Mammary Gland Biol Neoplasia 5(1):65-73.
15. Flint DJ, Beattie J, Allan GJ. 2003. Modulation of the actions of IGFs by IGFBP-5 in the mammary gland. Horm Metab Res 35(11-12):809-815.
16. Hurley WL, Blatchford DR, Hendry KA, Wilde CJ. 1994. Extracellular matrix and mouse mammary cell function: Comparison of substrata in culture. In Vitro Cell Dev Biol Anim 30A(8):529-538.
17. Huynh H, Yang XF, Pollak M. 1996. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7(11):1501-1506.
18. Imai Y, Busby WH, Jr., Smith CE, Clarke JB, Garmong AJ, Horwitz GD, Rees C, Clemmons DR. 1997. Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture. J Clin Invest 100(10):2596-2605.
19. Kanatani M, Sugimoto T, Nishiyama K, Chihara K. 2000. Stimulatory effect of insulin-like growth factor binding protein-5 on mouse osteoclast formation and osteoclastic bone-resorbing activity. J Bone Miner Res 15(5):902-910.
20. Kleinberg DL. 1998. Role of IGF-I in normal mammary development. Breast Cancer Res Treat 47(3):201-208.
21. Kolek O, Gajkowska B, Godlewski MM, Motyl T. 2001. Molecular mechanism of TGF-beta1-induced apoptosis in HC11 mouse mammary epithelial cells (MEC). Cell Mol Biol (Noisy-le-grand) 47 Online Pub:OL197-208.
22. Laursen LS, Overgaard MT, Soe R, Boldt HB, Sottrup-Jensen L, Giudice LC, Conover CA, Oxvig C. 2001. Pregnancy-associated plasma protein-A (PAPP-A) cleaves insulin-like growth factor binding protein (IGFBP)-5 independent of IGF: Implications for the mechanism of IGFBP-4 proteolysis by PAPP-A. FEBS Lett 504(1-2):36-40.
23. Marshman E, Green KA, Flint DJ, White A, Streuli CH, Westwood M. 2003. Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J Cell Sci 116(Pt 4):675-682.
24. McCaig C, Perks CM, Holly JM. 2002a. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: Inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J Cell Sci 115(Pt 22):4293-4303.
25. McCaig C, Perks CM, Holly JM. 2002b. Signalling pathways involved in the direct effects of IGFBP-5 on breast epithelial cell attachment and survival. J Cell Biochem 84(4):784-794.
26. Mieth M, Boehmer FD, Ball R, Groner B, Grosse R. 1990. Transforming growth factor-beta inhibits lactogenic hormone induction of beta-casein expression in HCIl mouse mammary epithelial cells. Growth Factors 4(1):9-15.
27. Motyl T, Gajkowska B, Ploszaj T, Wareski P, Skierski J, Zimowska W. 2000. Expression and subcellular redistribution of Bax during TGF-beta1-induced programmed cell death of HC11 mouse mammary epithelial cells. Cell Mol Biol (Noisy-le-grand) 46(1):175-185.
28. Murtagh J, McArdle E, Gilligan E, Thornton L, Furlong F, Martin F. 2004. Organization of mammary epithelial cells into 3D acinar structures requires glucocorticoid and JNK signaling. J Cell Biol 166(1):133-143.
29. Nguyen AV, Pollard JW. 2000. Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127(14):3107-3118.
30. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376(6535):37-43.
31. Oh Y, Muller HL, Lamson G, Rosenfeld RG. 1993. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem 268(20):14964-14971.
32. Phillips K, Park MA, Quarrie LH, Boutinaud M, Lochrie JD, Flint DJ, Allan GJ, Beattie J. 2003. Hormonal control of IGF-binding protein (IGFBP)-5 and IGFBP-2 secretion during differentiation of the HC11 mouse mammary epithelial cell line. J Mol Endocrinol 31(1):197-208.
33. Pollard JW. 2001. Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res 3(4):230-237.
34. Richman C, Baylink DJ, Lang K, Dony C, Mohan S. 1999. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140(10):4699-4705.
35. Robinson SD, Roberts AB, Daniel CW. 1993. TGF beta suppresses casein synthesis in mouse mammary explants and may play a role in controlling milk levels during pregnancy. J Cell Biol 120(1):245-251.
36. Rosato R, Lindenbergh-Kortleve D, Neck JV, Drop S, Jahn G. 2002. Effect of chronic thyroxine treatment on IGF-I, IGF-II and IGF-binding protein expression in mammary gland and liver during pregnancy and early lactation in rats. Eur J Endocrinol 146(5):729-739.
37. Rotwein P, James PL, Kou K. 1995. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol Endocrinol 9(7):913-923.
38. Rozen F, Yang XF, Huynh H, Pollak M. 1997. Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation. J Natl Cancer Inst 89(9):652-656.
39. Ruan W, Kleinberg DL. 1999. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 140(11):5075-5081.
40. Rudolph MC, McManaman JL, Hunter L, Phang T, Neville MC. 2003. Functional development of the mammary gland: Use of expression profiling and trajectory clustering to reveal changes in gene expression during pregnancy, lactation, and involution. J Mammary Gland Biol Neoplasia 8(3):287-307.
41. Schneider MR, Zhou R, Hoeflich A, Krebs O, Schmidt J, Mohan S, Wolf E, Lahm H. 2001. Insulin-like growth factor-binding protein-5 inhibits growth and induces differentiation of mouse osteosarcoma cells. Biochem Biophys Res Commun 288(2):435-442.
42. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76-85.
43. Tonner E, Beattie J, Flint DJ. 1995. Production of insulin-like growth factor binding protein (IGFBP), IGFBP-3 protease, and expression of IGF-I receptors by cells of the sheep immune system. Eur J Endocrinol 132(1):118-122.
44. Tonner E, Barber MC, Travers MT, Logan A, Flint DJ. 1997. Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology 138(12):5101-5107.
45. Tonner E, Allan G, Shkreta L, Webster J, Whitelaw CB, Flint DJ. 2000. Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Adv Exp Med Biol 480:45-53.
46. Tonner E, Barber MC, Allan GJ, Beattie J, Webster J, Whitelaw CB, Flint DJ. 2002. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development 129(19):4547-4557.
47. Wood TL, Richert MM, Stull MA, Allar MA. 2000. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands. J Mammary Gland Biol Neoplasia 5(1):31-42.
48. Yin P, Xu Q, Duan C. 2004. Paradoxical actions of endogenous and exogenous insulin-like growth factor binding protein (IGFBP)-5 revealed by RNA interference analysis. J Biol Chem.